In studies on the mechanisms of hemolysis in mammalian erythrocytes, the role of the metabolism of the erythrocyte in the maintenance of the structural integrity of the cell has been increasingly appreciated. Detailed knowledge of the chemical and physical events that occur in various kinds of hemolysis is not yet available, however. The discovery of a genetically determined deficiency in the activity of glucose-6-phosphate dehydrogenase (G6PD) in the erythrocytes of certain individuals who experience hemolytic reactions upon exposure to various chemical agents (2) has provided opportunities for detailed study of some aspects of hemolysis. The life span of these enzymedeficient erythrocytes is normal (3) or only slightly shortened (4) in the absence of exposure to hemolytic substances. Obvious hemolysis does occur, however, when the subject is exposed to the fava bean, primaquine, and certain other chemicals. The deficiency in G6PD activity results in diminished regeneration of TPNH, which is required for the conversion of GSSG to GSH (5) . After the administration of primaquine to sensitive individuals, a marked decrease in erythrocyte GSH occurs just prior to the major hemolytic episode (6) . A rapid and marked decline in the content of GSH can be produced inl vitro upon incubation of deficient cells with a compound such as acetylphenylhydrazine (APH) (7) . The studies that are described in the present report were designed to provide more information *An abstract, presenting part of this work, has been published (1) . This investigation was supported by grant H-2803 from the National Institutes of Health, U. S. Public Health Service, and grant AT (30-1) 1855 from the Atomic Energy Commission. about the metabolic changes that occur in G6PD-deficient erythrocytes when they are exposed to APH and when the concentration of GSH in these erythrocytes is markedly diminished. Such information might help to determine whether the diminution in the concentration of GSH is correlated with other metabolic changes that might lead to enhanced susceptibility of the erythrocytes to hemolysis. Attention was directed to the effects of treatment with APH on glycolysis, the principal mechanism for the production of energy in the mature mammalian erythrocyte, and on the activities of certain of the enzymes in the glycolytic pathway that might be especially sensitive to the action of such compounds.
METHODS
A. Incubation. Blood was obtained from normal individuals and from adult Negro male subj ects whose erythrocytes were found to be deficient in G6PD activity as determined by the method of Kornberg and Horecker, modified by Marks (8) . The blood, anticoagulated with 1 mg of heparin per 10 ml of blood, was centrifuged, and after the plasma and buffy coat were removed, the cells were washed twice with 0.9% sodium chloride solution. The centrifugation and washing procedures were carried out at 40 C. Cell suspensions of 70%o were prepared in isotonic sodium phosphate buffer, pH 7.3, containing glucose, penicillin, and streptomycin. To samples of these suspensions, equal volumes of phosphate buffer alone or phosphate buffer containing APH, 5.0 mg per ml, were added. The final concentrations in the incubation mixtures were as follows: volume of packed red cells, 35%; glucose, 2.0 mg per ml; penicillin, 0.1 mg per ml; streptomycin, 0.1 mg per ml; and APH, 2.5 mg per ml. The samples were incubated in air in a Dubnoff metabolic shaker-incubator at 370 C for 7A hours. Samples of the incubation mixture were removed at 0, 2A, 5, and 72 hours for the various assays.
B. Assays. Lactic acid (LA) and pyruvic acid (PA) were determined by the methods of Barker and Summerson (9) and Friedemann and Haugen (10), respec-tively. One ml of incubation mixture and 6 ml of cold 2%o perchloric acid were mixed, and the clear filtrates were used for the assays. Glucose was determined by the method of Nelson (11) . Reduced glutathione was determined in metaphosphoric acid extracts of samples of the incubation mixtures by the method of Beutler (7) . The quantities of LA, PA, glucose, and GSH in the incubation mixtures were related to the volume of packed erythrocytes that was determined by the method of Wintrobe (12) . The values for production of LA and PA and for utilization of glucose during the period of incubation were derived from the differences between the amounts measured at the beginning and at the end of the incubation.
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RESULTS
Effects of APH treatment on glycolysis. Table  I presents data obtained from experiments in which normal and G6PD-deficient erythrocytes were incubated for 71 hours with glucose in the absence and in the presence of added APH. The findings may be summarized as follows. a) In the absence of APH, there was little or no accumulation of PA in either the normal or G6PD-deficient cells. b) On incubation of normal cells with APH, there was a decline in the formation of LA and an equivalent rise in the accumulation of PA. As a result, the ratio of the sum of LA plus PA in the presence of APH to the sum of LA plus PA in its absence approximated one. c) In G6PD-deficient cells, treatment with APH resulted in a greater decline in LA and a greater rise in PA than were observed in normal cells. The increased accumulation of PA, however, did not fully compensate for the marked diminution of LA, and the ratio of the sum of LA plus PA with APH to the sum of LA plus PA without APH was approximately 0.8. d) These findings were observed under con- In trying to elucidate the mechanism by which these effects were produced by APH in normal and in G6PD-deficient cells, we investigated the activity of some of the enzymes of the glycolytic pathway.
It has been suggested that a decline in GSH in the erythrocyte might inactivate or render more vulnerable to destruction those enzymes that appear to be dependent on sulfhydryl groups for their activity. A likely example of such an enzyme appeared to be GA3PD; GSH in bound form has been reported to be a constituent of this enzyme (16) . The activity of the enzyme was studied in normal and in G6PD-deficient erythrocytes at the beginning and after 74 hours of incubation in the absence and in the presence of added APH (Table III) (Table IV) . These results suggest that there might be a deficiency of the coenzyme Table V . DISCUSSION In considering whether a diminution in the content of GSH in G6PD-deficient erythrocytes plays a causal role in the destruction of these cells, it is important to determine whether there are demonstrable differences in the metabolic activities of normal and G6PD-deficient erythrocytes under conditions in which the level of GSH is only partially diminished in the normal cells, but virtually eliminated in the G6PD-deficient cells.
A difference in glucose utilization between normal and G6PD-deficient erythrocytes was noted after preincubating the cells with APH, removing the APH by washing, and reincubating the cells with glucose. Since present methods are not adequate for the measurement of glucose in the presence of APH (17) , the actual utilization of glucose by erythrocytes in the continued presence of APH is uncertain. Glycolytic activity in the presence of APH, however, could be evaluated by determining the formation of LA and PA. An accumulation of PA in both normal and G6PD-deficient erythrocytes occurred when they were treated with APH. But the effect of APH was much more pronounced in the deficient cells. The sum of LA and PA was not diminished in normal cells treated with APH, but was diminished in the G6PD-deficient cells. These results indicate that the glycolytic reactions by which ATP is regenerated are maintained in normal erythrocytes, but are reduced in deficient cells under the conditions of these experiments. These findings are consistent with the results of LUhr and Waller (18) , who reported diminished levels of ATP in deficient erythrocytes treated with primaquine, but not in normal cells. Mohler and Williams (19) also observed a significant fall in ATP content of deficient cells in their studies with phenylhydrazine hydrochloride, although there was some fall also in normal cells.
This effect of APH could not be ascribed to altered activities of GA3PD and LDH, since the activities of these enzymes were maintained despite a marked decline in free GSH. Although the measurement of enzyme activity in a lysate may not reflect exactly the activity of that enzymne within the intact cell, the observed activities of LDH and GA3PD were hundreds of times greater than would be required for the formation of the amounts of LA found. In the absence of a marked decrease in the measured activities of these enzymes, it would appear highly unlikely that the activities of these enzymes are rate limiting in the erythrocytes treated with APH. The maintenance of the activities of GA3PD and LDH in APHtreated cells is in agreement with the observations of L6hr and Waller in primaquine-treated cells (18) , but is at variance with the reported findings of Scheuch and Rapoport in erythrocytes treated with phenylhydrazine hydrochloride (20) . The latter described a marked decline in the activity of GA3PD after incubating rabbit erythrocytes with phenylhydrazine hydrochloride and concluded that the stability of GA3PD is closely tied to the presence of free GSH. However, no data were presented on the content of GSH in the mature rabbit erythrocytes before and after treatment with phenylhydrazine hydrochloride, and the activity of the enzyme immediately upon the addition of phenylhydrazine hydrochloride is also not described. On adding phenylhydrazine hydrochloride to rabbit erythrocytes in the same concentration they used, we have observed immediate denaturation of hemoglobin. This instantaneous effect was also observed by Jandl, Engle, and Allen (21) in their studies on human hemoglobin. It is probable that phenylhydrazine hydrochloride is directly injurious to cell constituents, including protein enzymes. Phenylhydrazine hydrochloride can oxidize GSH, but it does not follow necessarily that a decline in GSH must be attended by an immediate decline in the activity of GA3PD. The examination of this question requires conditions such as those that obtain in G6PD-deficient cells in which enzymatic activities can be studied in the virtual absence of free GSH.
The accumulation of PA might be due to an inadequate supply of DPNH. This possibility is supported by the finding of a decrease in DPNH when APH is added to a solution of DPNH with, and without, added hemolysate. GSH appears to prevent DPNH destruction by APH. The mechanism by which GSH protects DPNH under these conditions deserves further study.
The recent studies of Eldjarn and Bremer (22) may be pertinent to the findings reported here. On treatment of normal human erythrocytes with disulfides, they have found that the utilization of glucose by the erythrocytes is inhibited, but that the utilization of inosine or adenosine is unimpaired. They suggest, therefore, that the inhibitory effect of the disulfides is exercised at the hexokinase level, whereas other SH enzymes such as GA3PD seem to be unaffected.
The hypothesis that the diminution in glycolysis in erythrocytes depleted of GSH is a function of their hexokinase activity is currently under investigation.
SUMMARY
Studies on glucose-6-phosphate dehydrogenasedeficient erythrocytes reveal diminished glycolytic activity when the cells are depleted of their GSH by treatment with acetylphenylhydrazine (APH). Under these conditions no alteration occurs in the activity of glyceraldehyde-3-phosphate dehydrogenase and lactic dehydrogenase. This study indicates a possible role of GSH in preventing the oxidation of DPNH in the presence of agents such as APH.
